NCT05147233Phase 3Completed

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Study sponsor: Oculis

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-06-22Actual
Enrollment · participants241Actual
Source updated2025-07-11Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview